warnings
WARNINGS For external use only. Not for ophthalmic use.
Lidotral 3.88% Roll on
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Lidotral 3.88% Roll on
- Generic name
- LIDOCAINE HCI
- Manufacturer
- PureTek Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- db1085fe-0a1f-c4cc-e053-2a95a90aa838
- SPL ID
- db1085fe-0a1e-c4cc-e053-2a95a90aa838
- Version
- 1
- Effective date
- 2024-02-28
- Source export date
- 2026-10-27
- Source partition
- 3
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-27/d7629e6f844435cfe6cb0cf8c5341c46775ea16c5af42c77a22a2ffe820a2cd2/drug-label-0003-of-0014.json.zip
- Source manifest SHA-256
- 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
- Import run
- 20261027T193451Z
- Imported at
- 2026-10-27 19:48:52
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Lidotral 3.88% Roll on | openfda.brand_name | |
| generic name | LIDOCAINE HCI | openfda.generic_name | |
| manufacturer name | PureTek Corporation | openfda.manufacturer_name | |
| ndc | package | 59088-307-07 | openfda.package_ndc |
| ndc | product | 59088-307 | openfda.product_ndc |
| ndc11 | package | 59088030707 | derived:openfda.package_ndc |
| rxcui | 2675772 | openfda.rxcui | |
| rxcui | 2675768 | openfda.rxcui | |
| spl id | db1085fe-0a1e-c4cc-e053-2a95a90aa838 | id | |
| spl set id | db1085fe-0a1f-c4cc-e053-2a95a90aa838 | set_id | |
| unii | V13007Z41A | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.